Andrew Peller (ADW) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
3 Feb, 2026Executive summary
Fiscal 2024 revenue rose 1% to CAD 385.9 million, with Q4 revenue up 9.4% year-over-year to CAD 85.0 million, outperforming most peers in the Canadian wine industry.
Gross margin expanded to 39% for the year and 41.8% in Q4, driven by the Ontario VQA Support Program and cost-saving initiatives.
EBITDA grew 32.4% to CAD 50.3 million for the year, with Q4 EBITDA at CAD 9.3 million, reversing a prior year loss.
Net loss narrowed to CAD 2.9 million for the year and CAD 6.9 million in Q4, both improved from the previous year.
Navigated inflationary and supply chain challenges through cost-savings and operational improvements.
Financial highlights
Q4 sales rose 9.4% year-over-year to CAD 85.0 million; full-year sales up 1% to CAD 385.9 million.
Gross margin for the year increased 200 basis points to 39%, with a target of 41%-42% in the next two years.
EBITDA for the year was CAD 50.3 million, up 32% or CAD 12 million from the prior year.
Net loss per Class A share improved to CAD 0.07 for the year, from CAD 0.08 last year.
Cash provided by operations increased to CAD 38.1 million from CAD 13.8 million year-over-year.
Outlook and guidance
Management expects above-category sales performance and further margin and EBITDA growth.
Continued focus on cost savings, margin improvement, and operational efficiency.
Anticipates M&A opportunities to supplement organic growth, maintaining a historical 3%-4% top-line growth split between organic and acquisition.
Plans to capitalize on Ontario retail modernization and expansion in grocery, LCBO, and e-commerce channels.
Latest events from Andrew Peller
- Q3 2026 delivered higher revenue, margins, and earnings, with strong growth and a positive outlook.ADW
Q3 202614 Apr 2026 - Q2 margin and earnings growth, cost savings, and retail gains drive a positive outlook.ADW
Q2 20268 Apr 2026 - Q1 EBITA rose 25%, margins expanded, and debt fell amid strong big box and western sales.ADW
Q1 20268 Apr 2026 - Q3 revenue and earnings surged on big-box retail growth, margin gains, and cost savings.ADW
Q3 20258 Apr 2026 - Q2 revenue and EBITDA rose on retail gains, but net earnings fell as costs increased.ADW
Q2 20258 Apr 2026 - Record margins and innovation in health-focused products drive growth and future opportunities.ADW
Planet MicroCap Showcase: TORONTO 20253 Feb 2026 - EBITDA/EBITA grew to $12.9M despite a 1% sales drop, driven by cost savings and efficiency.ADW
Q1 20252 Feb 2026 - Net earnings rebounded to $11.1M on record revenue, margin gains, and lower debt.ADW
Q4 202513 Nov 2025 - Double-digit EBITA growth and margin expansion drive renewed profitability and long-term value.ADW
Investor Presentation2 Jul 2025